Stockhub

ABIONYX Pharma SA: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

29 August 2022

  • curprev 16:5916:59, 29 August 2022‎ Nick talk contribs‎ 1,285 bytes +1,285‎ Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == ABIONYX Pharma SA, a biotech company, discovers and develops therapies for the treatment of renal and ophthalmological diseases. The company is developing CER-001, a negatively-charged lipoprotein particle which contains human recombinant apoA-I, the natural high density lipoprotein (HDL) protein, and sphingomyelin and dipalmitoylphosphatidylglycerol natural phospholipids designed to mimicks the structural and functional bi..." Tag: Visual edit: Switched
Retrieved from ‘https://stockhub.co/research/ABIONYX_Pharma_SA’